Response to Khetan and Maitray's "Comment: Conservative management of massive choroidal relapse in retinoblastoma patients?"
Ophthalmic Genet
.
2018 Jun;39(3):417.
doi: 10.1080/13816810.2018.1453986.
Epub 2018 Mar 26.
Authors
Christina Stathopoulos
1
,
Marie-Claire Gaillard
1
,
Francesco Puccinelli
2
,
Philippe Maeder
2
,
Doris Hadjistilianou
3
,
Maja Beck-Popovic
4
,
Francis Munier
1
Affiliations
1
a Department of Ophthalmology , University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des aveugles , Lausanne , Switzerland.
2
b Department of Radiology , Centre Hospitalier Universitaire Vaudois , Lausanne , Switzerland.
3
c Unit of Ophthalmology , University of Siena , Siena , Italy.
4
d Unit of Pediatric Hemato-Oncology , Centre Hospitalier Universitaire Vaudois , Lausanne , Switzerland.
PMID:
29578815
DOI:
10.1080/13816810.2018.1453986
No abstract available
Publication types
Comment
MeSH terms
Choroid
Conservative Treatment
Humans
Neoplasm Recurrence, Local*
Retinal Neoplasms
Retinoblastoma*